Bio Light Headed for Biggest Gain in Month on Glaucoma Permit
Stock Chart for Bio Light Israeli Life Sciences Investments Ltd (BOLT)
Bio Light Israeli Life Sciences Investments Ltd. (BOLT) headed for its biggest gain in more than a month after the developer of drugs and medical technology said a unit got approval to market a glaucoma surgery device.
The shares advanced 2.1 percent, headed for the biggest gain since Feb. 21, to 0.197 shekel at 11 a.m. in Tel Aviv, giving the Ramat Gan, Israel-based company a market value of 35 million shekels ($9.3 million).
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.